Michael Kunz

895 total citations
49 papers, 523 citations indexed

About

Michael Kunz is a scholar working on Public Health, Environmental and Occupational Health, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Kunz has authored 49 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 14 papers in Cardiology and Cardiovascular Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Kunz's work include Blood Pressure and Hypertension Studies (12 papers), Reproductive Health and Contraception (12 papers) and Hormonal Regulation and Hypertension (5 papers). Michael Kunz is often cited by papers focused on Blood Pressure and Hypertension Studies (12 papers), Reproductive Health and Contraception (12 papers) and Hormonal Regulation and Hypertension (5 papers). Michael Kunz collaborates with scholars based in Germany, United States and Switzerland. Michael Kunz's co-authors include Joachim Marr, Kristina Gemzell‐Danielsson, Pirjo Inki, Oskari Heikinheimo, Felix Mahfoud, Eeva Lukkari‐Lax, Leena Anttila, Jan Endrikat, W. Schmidt and Lucas Lauder and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hypertension.

In The Last Decade

Michael Kunz

48 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Kunz Germany	12	217	130	114	79	74	49	523
Jason Tan Australia	13	142 0.7×	87 0.7×	89 0.8×	67 0.8×	22 0.3×	23	805
Jorge Braga Portugal	16	229 1.1×	53 0.4×	165 1.4×	185 2.3×	32 0.4×	61	682
Kate Webber Australia	15	88 0.4×	55 0.4×	22 0.2×	136 1.7×	55 0.7×	47	669
Hamid Reza Nakhai-Pour Canada	14	228 1.1×	27 0.2×	110 1.0×	112 1.4×	43 0.6×	22	611
Trond Melbye Michelsen Norway	15	114 0.5×	151 1.2×	319 2.8×	249 3.2×	26 0.4×	48	688
Özlem Seçilmiş Kerimoğlu Türkiye	12	134 0.6×	191 1.5×	120 1.1×	76 1.0×	17 0.2×	46	426
Nathalie C. Støer Norway	14	133 0.6×	17 0.1×	75 0.7×	66 0.8×	62 0.8×	48	597
Onur Güralp Türkiye	19	347 1.6×	259 2.0×	313 2.7×	332 4.2×	25 0.3×	69	890
Dağıstan Tolga Arıöz Türkiye	14	102 0.5×	116 0.9×	166 1.5×	117 1.5×	8 0.1×	52	527
Yu‐Chen Yeh United States	13	158 0.7×	152 1.2×	105 0.9×	29 0.4×	11 0.1×	28	551

Countries citing papers authored by Michael Kunz

Since Specialization

Citations

This map shows the geographic impact of Michael Kunz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kunz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kunz more than expected).

Fields of papers citing papers by Michael Kunz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kunz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kunz. The network helps show where Michael Kunz may publish in the future.

Co-authorship network of co-authors of Michael Kunz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kunz. A scholar is included among the top collaborators of Michael Kunz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kunz. Michael Kunz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kunz, Michael, Lea Wagmann, Michael Schuster, et al.. (2025). Unveiling Cardiac Complications: A Case of Amisulpride Overdose Leading to Bradycardia, QT-Prolongation, and Torsade de Pointes Tachycardia. Therapeutic Drug Monitoring. 47(4). 462–465.

Kunz, Michael, Kirk M. Welker, Lucas Lauder, et al.. (2025). Medication Adherence in Patients with Acutely Decompensated Heart Failure: A Cross-Sectional Study in the Emergency Department (ADHF-ED). European Journal of Heart Failure. 27(12). 2763–2772. 1 indexed citations

Götzinger, Felix, Michael Kunz, Lucas Lauder, Michael Böhm, & Felix Mahfoud. (2024). New ways of mitigating aldosterone in cardiorenal disease. European Heart Journal - Cardiovascular Pharmacotherapy. 10(6). 557–565. 6 indexed citations

Delles, Christian, Roland E. Schmieder, Rónán Daly, et al.. (2024). Response of Blood Pressure to Renal Denervation Is Not Associated With Genetic Variants. Hypertension. 82(1). 118–125. 1 indexed citations

Lauder, Lucas, Justyna Siwy, Michael Kunz, et al.. (2024). Impact of Renal Denervation on Urinary Peptide-Based Biomarkers in Hypertension. Hypertension. 81(6). 1374–1382. 2 indexed citations

Kulenthiran, Saarraaken, Lucas Lauder, Juliane Dederer, et al.. (2024). Ultra-long-term efficacy and safety of catheter-based renal denervation in resistant hypertension: 10-year follow-up outcomes. Clinical Research in Cardiology. 113(10). 1384–1392. 8 indexed citations

Emrich, Insa E., John W. Pickering, Felix Götzinger, et al.. (2024). Comparison of three creatinine-based equations to predict adverse outcome in a cardiovascular high-risk cohort: an investigation using the SPRINT research materials. Clinical Kidney Journal. 17(2). sfae011–sfae011. 1 indexed citations

Kunz, Michael, et al.. (2024). Studying drug excretion into exhaled breath aerosol – A workflow based on an impaction sampling device and LC-HRMS/MS analysis. Analytica Chimica Acta. 1323. 342991–342991. 3 indexed citations

Götzinger, Felix, Michael Kunz, Lucas Lauder, Felix Mahfoud, & Michael Böhm. (2023). Radio Frequency-Based Renal Denervation: A Story of Simplicity?. Future Cardiology. 19(9). 431–440. 1 indexed citations

10.

Kunz, Michael, Felix Götzinger, Insa E. Emrich, et al.. (2022). Cardio-renal interaction - Clinical trials update 2022. Nutrition Metabolism and Cardiovascular Diseases. 32(11). 2451–2458. 4 indexed citations

11.

Götzinger, Felix, Michael Kunz, Lucas Lauder, Michael Böhm, & Felix Mahfoud. (2022). Arterial hypertension - clinical trials update 2022. Hypertension Research. 45(7). 1140–1146. 4 indexed citations

12.

Kunz, Michael, et al.. (2021). Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS/MS. Analytica Chimica Acta. 1187. 339137–339137. 9 indexed citations

13.

Marr, Joachim, Christoph Gerlinger, & Michael Kunz. (2012). A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen. European Journal of Obstetrics & Gynecology and Reproductive Biology. 162(1). 91–95. 7 indexed citations

14.

Schipke, Carola G., Oliver Peters, Isabella Heuser, et al.. (2012). Impact of Beta-Amyloid-Specific Florbetaben PET Imaging on Confidence in Early Diagnosis of Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 33(6). 416–422. 54 indexed citations

15.

Anttila, Leena, W. Neunteufel, Felice Petraglia, Joachim Marr, & Michael Kunz. (2011). Cycle Control and Bleeding Pattern of a 24/4 Regimen of Drospirenone 3 mg/Ethinylestradiol 20 μg Compared with a 21/7 Regimen of Desogestrel 150 μg/Ethinylestradiol 20 μg. Clinical Drug Investigation. 31(8). 519–525. 7 indexed citations

16.

Heikinheimo, Oskari, Pirjo Inki, Michael Kunz, & Kristina Gemzell‐Danielsson. (2010). Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system. Human Reproduction. 25(6). 1423–1427. 10 indexed citations

17.

Endrikat, Jan, Heather Shapiro, Eeva Lukkari‐Lax, et al.. (2009). A Canadian, Multicentre Study Comparing the Efficacy of a Levonorgestrel-releasing Intrauterine System to an Oral Contraceptive in Women With Idiopathic Menorrhagia. Journal of Obstetrics and Gynaecology Canada. 31(4). 340–347. 55 indexed citations

18.

Gemzell‐Danielsson, Kristina, et al.. (2009). Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)--a multicentre prospective study. Human Reproduction. 25(2). 354–359. 33 indexed citations

19.

Vitolo, Umberto, Franck Morschhauser, John Radford, et al.. (2008). CONSOLIDATION OF FIRST REMISSION WITH 90Y-IBRITUMOMAB TIUXETAN IN ADVANCED FOLLICULAR NON-HODGKIN'S LYMPHOMA (FL): RESULTS FROM THE PHASE 3 RANDOMIZED FIRST-LINE INDOLENT TRIAL (FIT). Annals of Oncology. 19. 231–232. 1 indexed citations

20.

Kunz, Michael, et al.. (2007). Coadministration of Estradiol/Drospirenone and Indomethacin Does Not Cause Hyperkalemia in Healthy Postmenopausal Women: A Randomized Open‐Label Crossover Study. The Journal of Clinical Pharmacology. 47(6). 774–781. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact